- SEK18.41bn
- SEK22.60bn
- SEK16.72bn
Brief: Elekta Near-Term Sees Lower Sales In China And U.S.
Brief: Elekta Q3 Adjusted EBIT SEK 548 Million
Brief: Elekta Secures Major Win With IMSS
Brief: Elekta Unity To Collaborate With Moffitt Cancer Center
Top of the Street: EssilorLuxottica, Elekta, Serco
Brief: German Cancer Center Treats First Patient In The World With Elekta Evo CT-Linac
JPM sees challenges to continue for European medtech & services in H1
Brief: FDA Says Elekta Recalls Disposable Biopsy Needle Kits
Europe Research Roundup: B&M, Johnson Matthey, Weir Group
Elekta falls on surprise drop in Q2 orders, profit miss
Brief: Elekta Keeps Outlook Unchanged
Brief: Elekta Q2 Adjusted EBIT SEK 423 Million Vs. Estimate SEK 478 Million
Earnings Poll: Elekta AB second quarter results due on November 27
Europe Research Roundup: Arkema SA, Flatexdegiro AG, Mediobanca
Brief: Elekta Issues SEK 1.5 Bln Bond, Signs Revolving Credit Facility Of Sek 1 Bln
Brief: Elekta Evo Submitted To U.S. FDA For Premarket Approval
Brief: Elekta Evo Is Available For Sale, Marketing In Europe
Europe Research Roundup: Airtel Africa, Serica Energy, Volkswagen
Europe Research Roundup: Bank of Georgia, Tracsis, Victrex